About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT03192189

Development of a Decision-making Aid for Referring Severe Kidney Injury Patients for Nephrology Consultations

Acute kidney injury is a frequent and growing complication associated with a risk of progressing into a chronic kidney disease. Recent guidelines have recommended systematic consultations with a nephr...

Lead sponsor: Centre Hospitalier Universitaire de Nīmes•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire de Nīmes

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age \>18 years
•Suffering from acute kidney injury treated with dialysis
•hospitalized in a university center from August 2016 to December 2017 with severe AKI defined according to 2 of the 3 criterion definitions of KDIGO stage AKI: an increase in SCr above 354 μmol/Lor renal replacement therapy (RRT) indication, but not the 3-fold increase in SCr increase within 7 days with SCr below 354 μmol/L.
•The patient has been informed and does not oppose the study
•The patient is insured or the beneficiary of a health insurance policy

Exclusion Criteria

•The patients is under judicial protection or state guardianship
•Patient has chronic kidney disease(CKD) KDIGO stage 5
•It proves impossible to give the patient clear information
•patients living with kidney transplant
•plan dialysis for bilateral surgery nephrectomy
•patient refuse to participate and patients with no health insurance

Related studies

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

NCT06474169 · Chronic Kidney Diseases

RECRUITINGPhase 2

Intravesical Aminophylline for Urgent Ureteral Stenting in Acute Calculous Anuria

NCT07617948 · Acute Calculous Anuria, Ureteral Calculi, and more

Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient

NCT06369064 · Acute Kidney Injury, Continuous Renal Replacement Therapy, and more

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

NCT06517810 · Acute Kidney Injury, Acute Kidney Injury Due to Sepsis

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT05692388 · Diabetic Nephropathy Type 2 - Uncontrolled, Diabetes Mellitus, Type 2, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 17, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment319

Start dateAug 2016

Last updatedNov 17, 2025

Condition

Chronic Kidney Diseases Acute Kidney Injury

Locations shown

CHU Nimes

Nîmes

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 17, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions